Technical Analysis for VXRT - Vaxart, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical VXRT trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | -1.38% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -1.38% | |
| Narrow Range Bar | Range Contraction | -1.38% | |
| NR7 | Range Contraction | -1.38% | |
| Inside Day | Range Contraction | -1.38% | |
| Wide Bands | Range Expansion | -1.38% | |
| 20 DMA Resistance | Bearish | -6.41% | |
| 50 DMA Support | Bullish | -6.41% | |
| Wide Bands | Range Expansion | -6.41% | |
| Fell Below 20 DMA | Bearish | -1.83% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 4 minutes ago |
| Fell Below 50 DMA | 18 minutes ago |
| 50 DMA Support | about 1 hour ago |
| Down 1% | about 1 hour ago |
| Fell Below Previous Day's Low | about 1 hour ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/13/2019
Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Influenza Coronavirus Vaccine Vaccination Hepatitis B Papillomavirus HPV Seasonal Influenza Human Papilloma Virus Human Papillomavirus Infection
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Influenza Coronavirus Vaccine Vaccination Hepatitis B Papillomavirus HPV Seasonal Influenza Human Papilloma Virus Human Papillomavirus Infection
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 24.9 |
| 52 Week Low | 2.23 |
| Average Volume | 18,484,407 |
| 200-Day Moving Average | 7.12 |
| 50-Day Moving Average | 6.48 |
| 20-Day Moving Average | 6.94 |
| 10-Day Moving Average | 7.82 |
| Average True Range | 1.03 |
| ADX | 19.8 |
| +DI | 25.37 |
| -DI | 24.13 |
| Chandelier Exit (Long, 3 ATRs ) | 8.03 |
| Chandelier Exit (Short, 3 ATRs ) | 7.94 |
| Upper Bollinger Band | 10.00 |
| Lower Bollinger Band | 3.88 |
| Percent B (%b) | 0.43 |
| BandWidth | 88.16 |
| MACD Line | 0.21 |
| MACD Signal Line | 0.35 |
| MACD Histogram | -0.1384 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.26 | ||||
| Resistance 3 (R3) | 7.34 | 7.17 | 7.14 | ||
| Resistance 2 (R2) | 7.17 | 6.98 | 7.13 | 7.09 | |
| Resistance 1 (R1) | 6.84 | 6.86 | 6.76 | 6.76 | 7.05 |
| Pivot Point | 6.67 | 6.67 | 6.63 | 6.63 | 6.67 |
| Support 1 (S1) | 6.34 | 6.48 | 6.26 | 6.26 | 5.97 |
| Support 2 (S2) | 6.17 | 6.36 | 6.13 | 5.93 | |
| Support 3 (S3) | 5.84 | 6.17 | 5.89 | ||
| Support 4 (S4) | 5.76 |
